These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27648982)

  • 1. The healthcare costs of heart failure during the last five years of life: A retrospective cohort study.
    Hollingworth W; Biswas M; Maishman RL; Dayer MJ; McDonagh T; Purdy S; Reeves BC; Rogers CA; Williams R; Pufulete M
    Int J Cardiol; 2016 Dec; 224():132-138. PubMed ID: 27648982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health Care Costs for Patients with Heart Failure Escalate Nearly 3-Fold in Final Months of Life.
    Obi EN; Swindle JP; Turner SJ; Russo PA; Altan A
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1446-1456. PubMed ID: 27882835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
    Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
    Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial).
    Reed SD; Li Y; Dunlap ME; Kraus WE; Samsa GP; Schulman KA; Zile MR; Whellan DJ
    Am J Cardiol; 2012 Oct; 110(8):1150-5. PubMed ID: 22762718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost of inpatient management of heart failure patients: a microcosting study in the Irish healthcare setting.
    Morgan RB; McCullagh L; Barry M; Daly C
    Ir J Med Sci; 2017 May; 186(2):293-303. PubMed ID: 27864782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resource use in the last 6 months of life among patients with heart failure in Canada.
    Kaul P; McAlister FA; Ezekowitz JA; Bakal JA; Curtis LH; Quan H; Knudtson ML; Armstrong PW
    Arch Intern Med; 2011 Feb; 171(3):211-7. PubMed ID: 20937918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study.
    Murthy SK; James PD; Antonova L; Chalifoux M; Tanuseputro P
    PLoS One; 2017; 12(5):e0177211. PubMed ID: 28498877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and healthcare utilisation of patients with heart failure in Spain.
    Escobar C; Varela L; Palacios B; Capel M; Sicras A; Sicras A; Hormigo A; Alcázar R; Manito N; Botana M
    BMC Health Serv Res; 2020 Oct; 20(1):964. PubMed ID: 33081776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patients with heart failure in the last year of their life: the primary care perspective].
    D'Ambrosio G; Filippi A; Battaggia A; De Maria R; Cricelli C
    G Ital Cardiol (Rome); 2014 Oct; 15(10):569-76. PubMed ID: 25424021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare Costs for Acute Hospitalized and Chronic Heart Failure in South Korea: A Multi-Center Retrospective Cohort Study.
    Ku H; Chung WJ; Lee HY; Yoo BS; Choi JO; Han SW; Jang J; Lee EK; Kang SM
    Yonsei Med J; 2017 Sep; 58(5):944-953. PubMed ID: 28792137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care).
    Maru S; Byrnes J; Carrington MJ; Chan YK; Thompson DR; Stewart S; Scuffham PA;
    Int J Cardiol; 2015 Dec; 201():368-75. PubMed ID: 26310979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home-based advance care programme is effective in reducing hospitalisations of advanced heart failure patients: a clinical and healthcare cost study.
    Wong RC; Tan PT; Seow YH; Aziz S; Oo N; Seow SC; Seah A; Chai P
    Ann Acad Med Singap; 2013 Sep; 42(9):466-71. PubMed ID: 24162321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relating cause of death with place of care and healthcare costs in the last year of life for patients who died from cancer, chronic obstructive pulmonary disease, heart failure and dementia: A descriptive study using registry data.
    van der Plas AG; Oosterveld-Vlug MG; Pasman HR; Onwuteaka-Philipsen BD
    Palliat Med; 2017 Apr; 31(4):338-345. PubMed ID: 28056634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trial.
    Martinson M; Bharmi R; Dalal N; Abraham WT; Adamson PB
    Eur J Heart Fail; 2017 May; 19(5):652-660. PubMed ID: 27647784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heart failure in Apulia Region - Italy (Local Health Unit Barletta-Andria-Trani): analysis of the therapeutic pathways, healthcare resource consumption and related costs.].
    Perrone V; Sangiorgi D; Degli Esposti L; Modugno G; Dambrosio G; Diaferia G; Delvecchio B; Dell'Orco ML; Masullo M; Ancona D; Deluca G; Campanile V; Narracci O; Nica M; Colombo D; Buda S
    Recenti Prog Med; 2019 Jan; 110(1):23-32. PubMed ID: 30720014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between use of general practice and healthcare costs at the end of life: a data linkage study in New South Wales, Australia.
    Tran B; Falster MO; Girosi F; Jorm L
    BMJ Open; 2016 Jan; 6(1):e009410. PubMed ID: 26743704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifetime costs of medical care after heart failure diagnosis.
    Dunlay SM; Shah ND; Shi Q; Morlan B; VanHouten H; Long KH; Roger VL
    Circ Cardiovasc Qual Outcomes; 2011 Jan; 4(1):68-75. PubMed ID: 21139091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic burden of heart failure in Denmark from 1998 to 2016.
    Bundgaard JS; Mogensen UM; Christensen S; Ploug U; Rørth R; Ibsen R; Kjellberg J; Køber L
    Eur J Heart Fail; 2019 Dec; 21(12):1526-1531. PubMed ID: 31359583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study.
    Borghs S; Byram L; Chan J; Dedeken P; Logan J; Kiri V; Noack-Rink M; Patsalos PN; Thieffry S
    BMC Neurol; 2020 Jan; 20(1):7. PubMed ID: 31914953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.